High Expectations for Immunotherapy in GI Cancers

High Expectations for Immunotherapy in GI Cancers

Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.

BY ARLENE WEINTRAUB

PUBLISHED MARCH 18, 2018

RHONDA BALL could see and feel a tumor on her stomach shrinking after she started taking Keytruda. - PHOTO BY AMY TANNENBAUM